112 related articles for article (PubMed ID: 37721089)
1. A partial agonist of PPARγ prevents paclitaxel-induced peripheral neuropathy in mice, by inhibiting neuroinflammation.
Benvenutti L; Wolff FR; Corrêa TP; Melato J; Goldoni FC; De Faveri R; Patel YBK; de Souza JA; Grockoski HA; Nilz PM; Bombardelli CL; Remor AP; Varela KG; Costa NTC; Hernandes MZ; Lacerda MG; Rodrigues KD; Milton FA; Neves FAR; Pereira MES; Kormann Imianowsky EC; de Campos Buzzi F; Brunaldi Marutani VH; Stoeberl LC; Correa R; Eller S; de Oliveira TF; Gonçalves TBP; da Silva RC; Passos GF; da Costa R; Santin JR; Quintão NLM
Br J Pharmacol; 2024 Apr; 181(7):1128-1149. PubMed ID: 37721089
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic diet prevents paclitaxel-induced neuropathic nociception through activation of PPARγ signalling pathway and inhibition of neuroinflammation in rat dorsal root ganglion.
Zhong S; Zhou Z; Lin X; Liu F; Liu C; Liu Z; Deng W; Zhang X; Chang H; Zhao C
Eur J Neurosci; 2021 Aug; 54(4):5341-5356. PubMed ID: 34318540
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Tonello R; Lee SH; Berta T
J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
[TBL] [Abstract][Full Text] [Related]
4. Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M; Imai S; Matsumoto M; Iguma Y; Kawaguchi-Sakita N; Kotake T; Iwamitsu Y; Ntogwa M; Hiraiwa R; Nagayasu K; Saigo M; Ogihara T; Yonezawa A; Omura T; Nakagawa S; Nakagawa T; Matsubara K
Cancer Res; 2021 Apr; 81(8):2207-2219. PubMed ID: 33608316
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid alleviates paclitaxel-induced peripheral neuropathy through PPARγ activation.
Yang Y; He Z; Wu S
Toxicol Appl Pharmacol; 2024 Mar; 484():116883. PubMed ID: 38437959
[TBL] [Abstract][Full Text] [Related]
6. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice.
Wu D; Eeda V; Undi RB; Mann S; Stout M; Lim HY; Wang W
Mol Metab; 2021 Dec; 54():101363. PubMed ID: 34710641
[TBL] [Abstract][Full Text] [Related]
7. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
[TBL] [Abstract][Full Text] [Related]
8. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
Mansooralavi N; Khomula EV; Levine JD
Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN.
Henique C; Bollee G; Lenoir O; Dhaun N; Camus M; Chipont A; Flosseau K; Mandet C; Yamamoto M; Karras A; Thervet E; Bruneval P; Nochy D; Mesnard L; Tharaux PL
J Am Soc Nephrol; 2016 Jan; 27(1):172-88. PubMed ID: 25999406
[TBL] [Abstract][Full Text] [Related]
11. PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway.
Zhou YQ; Liu DQ; Chen SP; Chen N; Sun J; Wang XM; Li DY; Tian YK; Ye DW
Biomed Pharmacother; 2020 Sep; 129():110356. PubMed ID: 32535388
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
Galli A; Ceni E; Mello T; Polvani S; Tarocchi M; Buccoliero F; Lisi F; Cioni L; Ottanelli B; Foresta V; Mastrobuoni G; Moneti G; Pieraccini G; Surrenti C; Milani S
Hepatology; 2010 Aug; 52(2):493-505. PubMed ID: 20683949
[TBL] [Abstract][Full Text] [Related]
13. Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.
Kyte SL; Toma W; Bagdas D; Meade JA; Schurman LD; Lichtman AH; Chen ZJ; Del Fabbro E; Fang X; Bigbee JW; Damaj MI; Gewirtz DA
J Pharmacol Exp Ther; 2018 Jan; 364(1):110-119. PubMed ID: 29042416
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress.
Zhang M; Hu M; Alles SRA; Montera MA; Adams I; Santi MD; Inoue K; Tu NH; Westlund KN; Ye Y
Neuropharmacology; 2022 Nov; 218():109233. PubMed ID: 36007855
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy.
Itoh K; Shimoyama M; Schiller PW; Toyama S
Chem Biol Drug Des; 2023 Apr; 101(4):1012-1018. PubMed ID: 36513390
[TBL] [Abstract][Full Text] [Related]
16. Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy.
Chen LH; Yeh YM; Chen YF; Hsu YH; Wang HH; Lin PC; Chang LY; Lin CK; Chang MS; Shen MR
Pain; 2020 Jun; 161(6):1237-1254. PubMed ID: 32068666
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo.
Bhalla K; Hwang BJ; Choi JH; Dewi R; Ou L; Mclenithan J; Twaddel W; Pozharski E; Stock J; Girnun GD
J Biol Chem; 2011 Dec; 286(48):41626-41635. PubMed ID: 21979952
[TBL] [Abstract][Full Text] [Related]
18. Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway.
Sun H; Guo X; Wang Z; Wang P; Zhang Z; Dong J; Zhuang R; Zhou Y; Ma G; Cai W
Oxid Med Cell Longev; 2019; 2019():3142732. PubMed ID: 30881589
[TBL] [Abstract][Full Text] [Related]
19. An exercise regimen prevents development paclitaxel induced peripheral neuropathy in a mouse model.
Park JS; Kim S; Hoke A
J Peripher Nerv Syst; 2015 Mar; 20(1):7-14. PubMed ID: 25858462
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions.
Brandolini L; d'Angelo M; Novelli R; Castelli V; Giorgio C; Sirico A; Cocchiaro P; D'Egidio F; Benedetti E; Cristiano C; Bugatti A; Ruocco A; Amendola PG; Talarico C; Manelfi C; Iaconis D; Beccari A; Quadros AU; Cunha TM; Caruso A; Russo R; Cimini A; Aramini A; Allegretti M
Cell Death Dis; 2022 May; 13(5):500. PubMed ID: 35614037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
